For the Inventor, By the Inventor

Enter assignee name

Institute Pasteur

USPTO Granted Patents = 17

Forward Citations = 88

Loading Chart...

Loading Chart...

75 inventors (with patents filed for the assignee):

Luc Montagnier (3 out of 112 patents)

André Choulika (2 out of 10 patents)

Richard C Mulligan (2 out of 33 patents)

4. Sylvie Van Der Werf (2 out of 4 patents)

5. Henri Agut (2 out of 3 patents)

6. Helene Collandre (2 out of 2 patents)

7. Jean-Marie Bechet (2 out of 2 patents)

8. Pierre Charneau (1 out of 35 patents)

9. Frédéric Tangy (1 out of 35 patents)

10. Nicolas Robert Xavier Escriou (1 out of 2 patents)

11. Chantal Combredet (1 out of 15 patents)

12. Nicolas Escriou (1 out of 5 patents)

13. Pedro Alzari (1 out of 12 patents)

14. Francois Traincard (1 out of 9 patents)

15. Jean-Claude Manuguerra (1 out of 7 patents)

17 patents: Sort by Forward Citations

1. 10018629 - Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus (2018-07-10),

2. 7960525 - Gene repair involving in vivo excision of targeting DNA (2011-06-14),

3. 7736850 - Strain of SARS-associated coronavirus and applications thereof (2010-06-15),

4. 7585656 - Crystallographic structure of TcPRACA and uses therefor (2009-09-08),

5. 7285538 - Gene repair involving in vivo excision of targeting DNA (2007-10-23),

6. 7217801 - Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products (2007-05-15),

7. 7030234 - Non-M, non-O HIV-1 strains, fragments and uses (2006-04-18),

8. 6958235 - Recombinant protein containing a C-terminal fragment of plasmodium MSP-1 (2005-10-25),

9. 6916607 - PEPTIDES AND POLYPEPTIDES DERIVED FROM THE SUBMAXILLARY GLAND OF THE RAT CORRESPONDING POLYCLONAL AND MONOCLONAL ANTIBODIES CORRESPONDING HYBRIDOMAS AND USES OF THESE PRODUCTS FOR DIAGNOSIS FOR DETECTION OR THERAPEUTIC PURPOSES (2005-07-12),

10. 6800492 - Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level (2004-10-05),

11. 6723559 - RECOMBINANT SEGMENTED NEGATIVE STRAND VIRUS CONTAINING BICISTRONIC VRNA SEGMENT WITH A DUPLICATION OF ITS 3′ NONCODING FLANKING SEQUENCE, AND VACCINES AND THERAPEUTIC COMPOSITIONS CONTAINING THE SAME (2004-04-20),

12. 6261571 - Immunogenic compositions comprising dimeric forms of the human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) envelope glycoproteins (2001-07-17),

13. 5876922 - Papillomavirus probe and a process for in vitro diagnosis of (1999-03-02),

14. 5817459 - Nucleotide sequences of actinomycetales, oligonucleotides of said (1998-10-06),

15. 5698392 - Nucleic acid fragments and diagnostic reagents derived from the HHV6/SIE (1997-12-16),

The Institut Pasteur is a globally renowned biomedical research institute, dedicated to studying and preventing infectious diseases. Established in 1887 in Paris, France, the institute has made significant contributions to the fields of microbiology, immunology, and virology. With a network of researchers and laboratories worldwide, Institut Pasteur conducts cutting-edge research, collaborates with international partners, and provides education and training programs in the field of life sciences.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

17 Patents

#245 in Paris

#1,127 in France

#34,819 in the World

Institute Pasteur

Forward Citations = 88

75 inventors:

Luc Montagnier (3 out of 112 patents)

André Choulika (2 out of 10 patents)

Richard C Mulligan (2 out of 33 patents)

4. Sylvie Van Der Werf (2 out of 4 patents)

5. Henri Agut (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…